Loading...
Inspire Medical Systems, Inc.
INSP•NYSE
Healthcare
Medical - Devices
$130.73
$1.87(1.45%)
Inspire Medical Systems, Inc. (INSP) Financial Performance & Income Statement Overview
Review Inspire Medical Systems, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
28.49%
↑ 28.49%
Operating Income Growth
189.60%
↑ 189.60%
Net Income Growth
352.96%
↑ 352.96%
Operating Cash Flow Growth
428.32%
↑ 428.32%
Operating Margin
5.93%
↑ 5.93%
Gross Margin
84.65%
↑ 84.65%
Net Profit Margin
7.92%
↑ 7.92%
ROE
10.001%
↑ 10.001%
ROIC
7.46%
↑ 7.46%
Inspire Medical Systems, Inc. (INSP) Income Statement & Financial Overview
Review Inspire Medical Systems, Inc.'s (INSP) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $239.72M | $203.19M | $195.88M | $164.01M |
| Cost of Revenue | $35.99M | $32.40M | $29.84M | $24.76M |
| Gross Profit | $203.73M | $170.79M | $166.04M | $139.25M |
| Gross Profit Ratio | $0.85 | $0.84 | $0.85 | $0.85 |
| R&D Expenses | $30.34M | $26.08M | $28.86M | $28.85M |
| SG&A Expenses | $141.51M | $130.39M | $132.08M | $125.62M |
| Operating Expenses | $171.85M | $156.47M | $160.94M | $154.47M |
| Total Costs & Expenses | $207.83M | $188.87M | $190.79M | $179.23M |
| Interest Income | $5.55M | $5.89M | $5.88M | $5.92M |
| Interest Expense | $22000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2.48M | $1.85M | $1.38M | $839000.00 |
| EBITDA | $39.14M | $16.17M | $6.48M | -$14.38M |
| EBITDA Ratio | $0.16 | $0.08 | $0.03 | -$0.09 |
| Operating Income | $31.88M | $14.32M | $5.10M | -$15.22M |
| Operating Income Ratio | $0.13 | $0.07 | $0.03 | -$0.09 |
| Other Income/Expenses (Net) | $4.75M | $6.008M | $5.75M | $5.86M |
| Income Before Tax | $36.64M | $20.33M | $10.85M | -$9.36M |
| Income Before Tax Ratio | $0.15 | $0.10 | $0.06 | -$0.06 |
| Income Tax Expense | $1.41M | $1.83M | $1.05M | $650000.00 |
| Net Income | $35.22M | $18.50M | $9.79M | -$10.005M |
| Net Income Ratio | $0.15 | $0.09 | $0.05 | -$0.06 |
| EPS | $1.18 | $0.62 | $0.33 | -$0.34 |
| Diluted EPS | $1.15 | $0.60 | $0.32 | -$0.34 |
| Weighted Avg Shares Outstanding | $29.83M | $29.88M | $29.73M | $29.62M |
| Weighted Avg Shares Outstanding (Diluted) | $30.75M | $30.63M | $30.41M | $29.62M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan